Alexis Lafrenière is one of the easiest Rangers names to throw into trade rumors, but the real picture is more specific than that. There is no confirmed report that has formally put him on the block.
Alexis Lafrenière #13 of the New York Rangers Photo credit: Jack.SMart@prohockeynews.com
What stands out right now is how the wider league is being priced. Current NHL odds show tightly clustered lines across the board, with matchups like Devils vs Bruins (2.67 vs 2.23) and Ducks vs Wild (2.44 vs 2.41) sitting almost level. That kind of pricing reflects a league where the gap between teams is minimal, and where roster inefficiencies are exposed quickly. For a team like the Rangers, sitting outside the playoff picture, that pressure is amplified.
What is confirmed is that the Rangers have missed the playoffs for a second straight season, finishing 28-35-9 at the point of elimination and entering an offseason framed as a search for answers after another collapse. The league’s own review pointed to weak home form, injuries, and a midseason retool letter from Chris Drury as central reasons the season went off course.
A Reset Driven by Underperformance
That context matters because Lafrenière is not being discussed in a vacuum. He is being discussed because the Rangers are clearly in evaluation mode again.
Drury already signaled a willingness to reshape the roster when he told fans in January that the team was beginning a retool and would be saying goodbye to popular players.The Rangers hold 11 picks in the 2026 NHL Draft, their largest total in over two decades. This gives the front office more ways to rework the roster than a team trying to simply run it back.
The Lafrenière Dilemma
The Lafrenière case is tricky because his profile cuts both ways. On one hand, he is still only 24, was the No. 1 pick in 2020, and is no longer just a projection. He has become a real NHL top-six winger in stretches.
On the other side, the Rangers already committed major money to him. He signed a seven-year, $52.15 million extension in October 2024, carrying a $7.45 million average annual value through 2031-32.
At the time, that deal was sold as a long-term bet on a player coming off a breakout 57-point regular season and a 14-point playoff run to the Eastern Conference Final.
Production vs Expectations
That is where the pressure starts. A $7.45 million winger is not supposed to be a maybe. He is supposed to be a nightly difference-maker. Lafrenière has been good this season, but not so dominant that his name would be untouchable in a major retool.
NHL and ESPN data show he was sitting at 24 goals and 55 points in 79 games in 2025-26, which put him close to but still below the high-water mark he set in 2023-24. ESPN also noted he had five goals and six assists in his previous 12 outings, evidence that he was finishing strongly even as the team sank.
Late-Season Surge and Role Adjustments
That late push is one reason the situation is more complicated than rumor blogs make it sound. In the final stretch, Lafrenière was not fading into the background. He scored twice against Buffalo on April 8, and reached a career high in power-play points.
The real change in his game: more net-front work, more time around the crease, and a deliberate effort to get to harder scoring areas. Those are not the details of a player drifting out of relevance. They are the details of a player still being shaped.
Chemistry and Future Core Considerations
There is another detail that cuts in his favor: usage. When the Rangers found a productive mix late in the season, Lafrenière was skating with Mika Zibanejad and Gabe Perreault.
The coverage described Zibanejad as a bridge to the future and specifically noted his role in helping younger linemates such as Lafrenière. That matters because it suggests the Rangers still view him as part of a next core, not just a movable contract.
Trade Value and League Interest
So why does his name keep surfacing? Because he has actual market value. If New York wants to move a meaningful asset without gutting the entire roster, Lafrenière makes sense on paper.
He is young, under long-term control, and still carries upside that another club could believe it can unlock more fully. That is very different from a distressed sale. It would be a hockey trade if it happened, not a cap dump.
The contract is substantial, but it is not toxic, especially with the league cap rising and projecting the Rangers to have far more flexibility in 2026-27 than they have right now.
Wider Roster Pressure and Internal Changes
There is also a broader roster squeeze. Current reporting around the Rangers’ offseason highlights uncertainty beyond Lafrenière, including Braden Schneider’s future and competition for roster spots among younger players.
The front office is also addressing deeper issues in talent evaluation and development, reinforced by the return of Kevin Maxwell to a key scouting and player personnel role. The message there is clear: New York does not believe this is a one-player issue. It believes the organization needs sharper decisions across the board.
